Symrise AG cemented its leadership in key markets in 2025, delivering solid organic growth, record profitability, and efficiency gains that exceeded targets. The company credited its performance to disciplined execution of its ONE Symrise Strategy and the ONE SYM Transformation program.

 

For the full year, Symrise achieved organic sales growth of 2.8%, with reported revenues of €4.93 billion, despite foreign exchange and portfolio effects reducing revenue by €210 million. Adjusted EBITDA reached €1.081 billion, with a margin of 21.9%, up 120 basis points year-on-year, supported by €50 million in cost savings and efficiency gains, surpassing the €40 million target.

 

Dr. Jean-Yves Parisot, CEO of Symrise AG, said: "2025 was a year of disciplined execution guided by our purpose-driven ONE Symrise Strategy. We took decisive action to sharpen our portfolio and accelerate our transformation, focusing on the areas we can control to structurally enhance our competitiveness. 

 

"Targeted efficiency measures, disciplined cost management and continued investment in innovation and capacity expansion enabled Symrise to increase its adjusted EBITDA margin and significantly strengthen its cash conversion, providing a strong foundation for long‑term value creation.”

 

He added: “The launch of our first‑ever share buyback program, alongside our proposal for an increased dividend of €1.25, reflects our confidence in the strength of our business, our balance sheet and our future. With robust fundamentals, a resilient portfolio and a highly committed global team, we are well positioned to execute our strategy, generate durable, high‑quality earnings and create superior value for all stakeholders. This strength is built on the dedication of our people, and I want to thank the team who made it possible."

 

Financials:

 

Reported EBITDA: €913 million (down from €1.033 billion in 2024); Adjusted EBITDA: €1.081 billion (+€47 million), driven by sales growth, product mix, and ONE SYM Transformation efficiencies; Adjusted net income: €513 million (+€35 million);Adjusted EPS: €3.67 (+€0.25); including impairments, EPS was €1.78

 

Segment snapshots:

 

Taste, Nutrition & Health: Organic growth 2.6%, revenue €3.028 billion. Food & Beverage posted high single- to mid-digit growth across EAME and North America. Segment adjusted EBITDA rose to €722 million, with a margin of 23.8% (+160 bps).

 

Scent & Care: Organic growth 3.2%, revenue €1.901 billion. Fragrance division led high single-digit growth, while Cosmetic Ingredients saw a low single-digit decline. Adjusted EBITDA reached €359 million, margin 18.9% (+70 bps).

 

Symrise strengthened its financial position, with adjusted business free cash flow of €780 million (15.8% margin) and net debt of €1.62 billion, down €216 million from the previous year. The company proposed a dividend increase to €1.25 per share and launched its first share buyback program for up to €400 million, running from February through October 2026.